Authors:
TAYLOR LC
EVANS JM
POTHINI VM
HARTMAN E
FERGUSON L
PATWARDHAN AR
LEONELLI FM
KNAPP CF
Citation: Lc. Taylor et al., CHANGES IN PERIPHERAL-BLOOD FLOWS IN RESPONSE TO 48 HOURS OF 6-DEGREES HEAD-DOWN BED REST, The FASEB journal, 12(5), 1998, pp. 4020-4020
Authors:
EVANS JM
MCINTOSH CM
HARTMAN E
HARTMAN A
JULIAN TD
POTHINI VM
TAYLOR LC
PATWARDHAN AR
LEONELLI FM
ZIEGLER MG
KNAPP CF
Citation: Jm. Evans et al., CHANGES IN SYMPATHETIC PARASYMPATHIC BALANCE IN RESPONSE TO SHORT-TERM SIMULATED WEIGHTLESSNESS/, The FASEB journal, 12(5), 1998, pp. 4021-4021
Citation: Sh. Silverman et al., ON OUR OWN - PRELIMINARY FINDINGS FROM A CONSUMER-RUN SERVICE MODEL, Psychiatric rehabilitation journal, 21(2), 1997, pp. 151-159
Authors:
TAYLOR LC
KING KR
EVANS JM
KNAPP CF
PATWARDHAN AR
Citation: Lc. Taylor et al., EFFECTS OF HORMONAL CHANGES DURING MENSTRUAL-CYCLE ON CARDIOVASCULAR AUTONOMIC CONTROL, The FASEB journal, 11(3), 1997, pp. 281-281
Authors:
EVANS JM
MCINTOSH CM
TAYLOR LC
WANG K
KIM CS
KNAPP CF
LEONETTI FM
Citation: Jm. Evans et al., INCREASED RATE OF PLASMA FILTRATION IN SYNCOPAL VS NONSYNCOPAL SUBJECTS DURING 70-DEGREES TILT, The FASEB journal, 11(3), 1997, pp. 1477-1477
Authors:
KING KR
EVANS JM
TAYLOR LC
JULIAN CD
PATWARDHAN AR
KNAPP CF
LEONELLI FM
Citation: Kr. King et al., TIME-FREQUENCY ANALYSIS OF HEART-RATE IN DETERMINING POTENTIAL FOR SYNCOPE DURING HEAD-UP TILT, The FASEB journal, 11(3), 1997, pp. 1478-1478
Authors:
FRICK LW
LAMBE CU
STJOHN L
TAYLOR LC
NELSON DJ
Citation: Lw. Frick et al., PHARMACOKINETICS, ORAL BIOAVAILABILITY, AND METABOLISM IN MICE AND CYNOMOLGUS MONKEYS OF 5-FLUORO-1-[2-(HYDROXYMETHYL)-1,3-OXATHIOLAN-5-YL]CYTOSINE, AN AGENT ACTIVE AGAINST HUMAN-IMMUNODEFICIENCY-VIRUS AND HUMAN HEPATITIS-B VIRUS, Antimicrobial agents and chemotherapy, 38(12), 1994, pp. 2722-2729
Authors:
FRICK LW
STJOHN L
TAYLOR LC
PAINTER GR
FURMAN PA
LIOTTA DC
FURFINE ES
NELSON DJ
Citation: Lw. Frick et al., PHARMACOKINETICS, ORAL BIOAVAILABILITY, AND METABOLIC DISPOSITION IN RATS OF 5-FLUORO-1-[2-(HYDROXYMETHYL)-1,3-OXATHIOLAN-5-YL] CYTOSINE, ANUCLEOSIDE ANALOG ACTIVE AGAINST HUMAN-IMMUNODEFICIENCY-VIRUS AND HEPATITIS-B VIRUS, Antimicrobial agents and chemotherapy, 37(11), 1993, pp. 2285-2292